Sg3 Management, LLC Neurocrine Biosciences Inc Put Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $2.33 Million - $2.67 Million	-27,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $3.58 Million - $4.09 Million	-40,000 Reduced 59.7%	27,000 $2.63 Million
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $4.55 Million - $6.21 Million	52,000 Added 346.67%	67,000 $6.52 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $1.43 Million - $1.78 Million	-16,400 Reduced 52.23%	15,000 $1.44 Million
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $2.3 Million - $3.23 Million	23,900 Added 318.67%	31,400 $3.02 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $638,175 - $977,700	7,500 New	7,500 $915,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.